No Picture
Trading Ideas

EBay to sell ticketing unit StubHub for $4.05 billion

In January, activist investors Elliott Management Corp and Starboard Value had urged eBay to sell its ticket sales business and eBay Classifieds Group as part of a plan that could double the company’s value. Elliott valued StubHub between $3.5 billion and $4.5 billion, while eBay Classifieds between $8 billion and $12 billion. …read more […]

No Picture
Trading Ideas

Tesla shares rise as Musk says Cybertruck orders hit 200,000

Tesla Inc shares rose 4% on Monday after Chief Executive Officer Elon Musk tweeted over the weekend that the company had already received 200,000 orders for its futuristic Cybertruck pickup. Tesla opened preorders immediately, however, and allowed potential buyers to book the truck by depositing just $100, compared to the $1,000 Tesla charged for booking Model 3 sedans in 2016, drawing the flood of reservations and sending the company’s shares back up on Monday. From touting the features of the new vehicle to taking a dig at Ford rival F-150 pickup truck, Musk has been tweeting furiously to …read more […]

No Picture
Trading Ideas

UPDATE 1-CymaBay Therapeutics scraps liver disease studies; shares plunge

CymaBay Therapeutics Inc said on Monday it was scrapping two mid-stage studies testing its lead drug for two types of liver diseases after observing “atypical” findings in one of the trials, sending its shares down 79% in premarket trading. The atypical findings in non-alcoholic steatohepatitis (NASH) were observed in patients who had shown an improvement in their condition during the trial, or had shown signs of disease stabilization, it added. The second trial was testing the drug in patients with primary sclerosing cholangitis, a chronic disease that damages the bile ducts. …read more […]

No Picture
Trading Ideas

Hedge Funds Are Optimistic About Merck & Co., Inc. (MRK)

We can judge whether Merck & Co., Inc. (NYSE:MRK) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There’s no better way to get these firms’ immense resources and analytical capabilities working for us than to follow their lead into their […] …read more […]

No Picture
Trading Ideas

UPDATE 1-FDA declines to approve Adamis Pharma's Zimhi to treat opioid overdose

Adamis Pharmaceuticals Corp said on Monday the U.S. Food and Drug Administration declined to approve its opioid overdose treatment, raising questions around its chemistry, manufacturing and controls (CMC). In a letter to the company, the FDA questioned the treatment’s manufacturing process, but not its safety or effectiveness, Adamis said. The drug Zimhi is a naloxone pre-filled single dose syringe used for emergency treatment of known or suspected opioid overdose. …read more […]